Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Harold Engstrom who wrote (5103)	6/12/1998 9:13:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 9719

Harold: >> Have seen Rick's skeptic posts << Please note that I'm not negative about the company's prospects going forward, and have never expressed such. I just don't think that Robinson has focused on a lean machine. Proponents are constantly groping for something to support all those shares and all that spending, to make them look non-BTGC-like in the future. If it isn't diabetes, it's a cytokine receptor agonist. So, my only comment is.... given the lack of attention to shareholder equity, why don't LGND investors look for investments that are leveraged? I like the company/science, but the potential payback is not exceptional, relative to many other biotechs. Rick